Mon. Sep 26th, 2022


Bibliometric details: Edition No: 8 | Month of issue:August | Year of issue: 2022

India has approved Biological E’s Corbevax as a precautionary dose for the population over 18 years of age, Union Secretary Rajesh Bhushan said. It will be administered after six months from the date of administration of the second dose of both vaccines, Covaxin or Covishield.

In a letter to the states, Bhushan said: “Corbevax will be available as a precautionary dose after the completion of 6 months or 26 weeks from the date of administration of the second dose of the Covaxin or Covishield vaccines to the population aged 18 years and older. “.

More information | Gaze Says Other Booster-Inoculated People Recover More Than Three Days Sooner From Omicron Than Delta

In particular, this is the first time that a booster dose different from the extinct one for the fundamental vaccination against COVID-19 has been allowed in the country.

“In addition to the new homologous precautionary dose, the probability of a heterologous precautionary dose with Corbevax will be available to all other persons over the age of 18,” Bhushan said in the letter.

The Union ministry reportedly made the decision following suggestions from the COVID-19 Task Force of the National Technical Advisory Group on Immunization (NTAGI). He had reviewed the files of the double-blind randomized clinical search part 3 that evaluated the immunogenicity and safety of the Corbevax vaccine booster dose when administered to COVID-19 unfavorable adult volunteers aged 18 to 80 years…



Source link